Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study

Real-Life Experience with Pomalidomide plus Low-Dose Dexamethasone in Patients with Relapsed and Refractory Multiple Myeloma: A Retrospective and Prospective Study

<i>Background and Objectives</i><b>:</b> The treatment of Myeloma after the second relapse is still challenging. The aim of the study was to investigate the outcomes of the POM-DEX regimen in real clinical practice. <i>Materials and Methods:</i> We retrospectively...

Full description

Bibliographic Details
Main Authors: Maria Livia Del Giudice, Alessandro Gozzetti, Elisabetta Antonioli, Enrico Orciuolo, Francesco Ghio, Sara Ciofini, Veronica Candi, Giulia Fontanelli, Irene Attucci, Giuseppe Formica, Monica Bocchia, Sara Galimberti, Mario Petrini, Gabriele Buda
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Medicina
Subjects:
pomalidomide
dexamethasone
multiple myeloma
immunomodulatory therapy
real-world clinical trials
Online Access:https://www.mdpi.com/1648-9144/57/9/900

Internet

https://www.mdpi.com/1648-9144/57/9/900

Similar Items